Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1994 1
2000 1
2002 1
2010 1
2011 1
2013 3
2015 2
2016 1
2017 1
2019 8
2020 8
2021 9
2022 4
2023 0
Text availability
Article attribute
Article type
Publication date

Search Results

34 results
Results by year
Filters applied: . Clear all
Page 1
Evaluation and treatment of headache associated with moyamoya disease - a narrative review.
Chiang CC, Shahid AH, Harriott AM, Tietjen GE, Savastano LE, Klaas JP, Lanzino G. Chiang CC, et al. Cephalalgia. 2022 May;42(6):542-552. doi: 10.1177/03331024211056250. Epub 2021 Nov 17. Cephalalgia. 2022. PMID: 34786968 Review.
BACKGROUND: Headache in patients with moyamoya disease is an under-addressed topic in the medical literature. ...METHODS: We searched PubMed for keywords including moyamoya disease, moyamoya syndrome, headache in moyamoya, surgical revasc …
BACKGROUND: Headache in patients with moyamoya disease is an under-addressed topic in the medical literature. ...METHODS: We s …
Moyamoya disease versus moyamoya syndrome: comparison of presentation and outcome in 338 hemispheres.
Feghali J, Xu R, Yang W, Liew JA, Blakeley J, Ahn ES, Tamargo RJ, Huang J. Feghali J, et al. J Neurosurg. 2019 Oct 4:1-9. doi: 10.3171/2019.6.JNS191099. Online ahead of print. J Neurosurg. 2019. PMID: 31585423
OBJECTIVE: Phenotypic differences between moyamoya disease (MMD) and moyamoya syndrome (MMS) remain unclear. ...Baseline demographic, angiographic, and clinical characteristics were compared between patients with MMS and MMD, in addition to procedure-related …
OBJECTIVE: Phenotypic differences between moyamoya disease (MMD) and moyamoya syndrome (MMS) remain unclear. ...Baselin …
Contemporary and emerging magnetic resonance imaging methods for evaluation of moyamoya disease.
Lehman VT, Cogswell PM, Rinaldo L, Brinjikji W, Huston J, Klaas JP, Lanzino G. Lehman VT, et al. Neurosurg Focus. 2019 Dec 1;47(6):E6. doi: 10.3171/2019.9.FOCUS19616. Neurosurg Focus. 2019. PMID: 31786551 Review.
Numerous recent technological advances offer the potential to substantially enhance the MRI evaluation of moyamoya disease (MMD). These include high-resolution volumetric imaging, high-resolution vessel wall characterization, improved cerebral angiographic and perfu …
Numerous recent technological advances offer the potential to substantially enhance the MRI evaluation of moyamoya disease (MM …
Cardiac manifestations in a western moyamoya disease population: a single-center descriptive study and review.
Larson AS, Savastano L, Klaas J, Lanzino G. Larson AS, et al. Neurosurg Rev. 2021 Jun;44(3):1429-1436. doi: 10.1007/s10143-020-01327-x. Epub 2020 Jun 7. Neurosurg Rev. 2021. PMID: 32507930 Review.
An embryological association between moyamoya disease (MMD) and cardiac manifestations has been proposed. ...The objective of this study was to determine the prevalence of cardiac manifestations including coronary artery disease (CAD) and congenital cardiac d …
An embryological association between moyamoya disease (MMD) and cardiac manifestations has been proposed. ...The objective of …
Ischemic Infarction in Young Adults: A Review for Radiologists.
McCarty JL, Leung LY, Peterson RB, Sitton CW, Sarraj A, Riascos RF, Brinjikji W. McCarty JL, et al. Radiographics. 2019 Oct;39(6):1629-1648. doi: 10.1148/rg.2019190033. Radiographics. 2019. PMID: 31589580 Review.
Stroke remains the leading cause of serious disability in the United States. The consequences of this familiar disease in this atypical age group are especially detrimental and long lasting. ...However, compared with older adults, young adults have fewer ischemic infarcts …
Stroke remains the leading cause of serious disability in the United States. The consequences of this familiar disease in this atypic …
Ivy sign: a diagnostic and prognostic biomarker for pediatric moyamoya.
Montaser AS, Lalgudi Srinivasan H, Staffa SJ, Zurakowski D, Slingerland AL, Orbach DB, Hausman-Kedem M, Roth J, Smith ER. Montaser AS, et al. J Neurosurg Pediatr. 2021 Dec 31;29(4):458-466. doi: 10.3171/2021.11.PEDS21384. Print 2022 Apr 1. J Neurosurg Pediatr. 2021. PMID: 34972077
METHODS: Pre- and postoperative clinical and radiographic data of all pediatric patients (21 years of age or younger) who underwent surgery for moyamoya disease or moyamoya syndrome at two major tertiary referral centers in the US and Israel, between July 200 …
METHODS: Pre- and postoperative clinical and radiographic data of all pediatric patients (21 years of age or younger) who underwent surgery …
Current Clinical Applications of Intracranial Vessel Wall MR Imaging.
Mattay RR, Saucedo JF, Lehman VT, Xiao J, Obusez EC, Raymond SB, Fan Z, Song JW. Mattay RR, et al. Semin Ultrasound CT MR. 2021 Oct;42(5):463-473. doi: 10.1053/j.sult.2021.07.004. Epub 2021 Aug 1. Semin Ultrasound CT MR. 2021. PMID: 34537115 Free PMC article. Review.
We review the role of VWI for differentiating among steno-occlusive vasculopathies, such as intracranial atherosclerotic plaque, dissections and Moyamoya disease. We also highlight how VWI may be used for the diagnostic work-up and surveillance of patients with vasc …
We review the role of VWI for differentiating among steno-occlusive vasculopathies, such as intracranial atherosclerotic plaque, dissections …
Implementation and Rationale for a Unified Clinical and Imaging Protocol for Evaluation and Treatment of Moyamoya Angiopathy: A Single Institutional Experience.
Larson AS, Lehman VT, Savastano LE, Lanzino G, Campeau NG, Welker KM, Klaas JP. Larson AS, et al. Front Neurol. 2021 May 17;12:662393. doi: 10.3389/fneur.2021.662393. eCollection 2021. Front Neurol. 2021. PMID: 34079514 Free PMC article. Review.
Moyamoya disease (MMD) is a complex and incompletely-understood cerebrovascular pathological entity that requires thorough clinical and imaging evaluation. Moyamoya is rare, thereby making the establishment of an effective, thorough and interdisciplinary pati …
Moyamoya disease (MMD) is a complex and incompletely-understood cerebrovascular pathological entity that requires thorough cli …
Location-based treatment of intracranial aneurysms in moyamoya disease: a systematic review and descriptive analysis.
Larson AS, Rinaldo L, Brinjikji W, Lanzino G. Larson AS, et al. Neurosurg Rev. 2021 Apr;44(2):1127-1139. doi: 10.1007/s10143-020-01307-1. Epub 2020 May 8. Neurosurg Rev. 2021. PMID: 32385590
We conducted a systematic review of the literature to evaluate the efficacy of various treatment modalities for intracranial aneurysms (IA) in patients with moyamoya disease (MMD) based on anatomical location of IA. A comprehensive review of studies documenting sing …
We conducted a systematic review of the literature to evaluate the efficacy of various treatment modalities for intracranial aneurysms (IA) …
Clinical Characteristics of Moyamoya Angiopathy in a Pediatric Cohort.
Pines AR, Rodriguez D, Bendok BR, Dhamija R. Pines AR, et al. J Child Neurol. 2020 May;35(6):389-392. doi: 10.1177/0883073820902297. Epub 2020 Feb 24. J Child Neurol. 2020. PMID: 32089044
In most pediatric patients with this disease, the etiology is likely genetic. We aim to report clinical characteristics of a single-center cohort of pediatric patients with moyamoya. ...Fifty-five percent of our cohort were male, and the median age was 9 years. Thre …
In most pediatric patients with this disease, the etiology is likely genetic. We aim to report clinical characteristics of a single-c …
34 results